Big Pharma Flock to U.S. Manufacturing Amid Trump’s Tariff Threats
Pharmaceutical giants Johnson & Johnson, Eli Lilly, and Pfizer are following in each other’s footsteps by investing heavily in U.S. manufacturing after President Donald Trump threatened major tariffs on pharmaceutical products. Johnson & Johnson announced a $55 billion investment over the next four years, boosting its U.S. investment by 25% compared to previous investments. The … Read more